Diagnostics & Research
The Diagnostics & Research industry has a total of 47 stocks, with a combined market cap of $633.02 billion, total revenue of $165.59 billion and a weighted average PE ratio of 35.99.
Market Cap
633.02B
Revenue
165.59B
Profits
17.59B
PE Ratio
35.99
Profit Margin
10.62%
Dividend Yield
0.25%
47 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 176.09B | -3.04% | 800,042 | 44.56B |
| 2 | DHR | Danaher Corporation | 128.43B | -3.42% | 2,567,616 | 24.57B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 44.69B | -2.09% | 156,778 | 4.30B |
| 4 | A | Agilent Technologies, Inc. | 31.14B | -2.89% | 519,232 | 7.07B |
| 5 | WAT | Waters Corporation | 28.47B | -3.46% | 303,500 | 3.17B |
| 6 | IQV | IQVIA Holdings Inc. | 27.89B | -2.97% | 628,010 | 16.31B |
| 7 | NTRA | Natera, Inc. | 25.71B | -6.18% | 507,299 | 2.31B |
| 8 | MTD | Mettler-Toledo International Inc. | 25.04B | -3.01% | 58,204 | 4.03B |
| 9 | LH | Labcorp Holdings Inc. | 21.78B | -1.50% | 285,834 | 13.95B |
| 10 | DGX | Quest Diagnostics Incorporated | 21.49B | -1.42% | 435,637 | 11.04B |
| 11 | ILMN | Illumina, Inc. | 17.95B | -5.64% | 656,506 | 4.34B |
| 12 | MEDP | Medpace Holdings, Inc. | 12.85B | -2.96% | 75,631 | 2.53B |
| 13 | GH | Guardant Health, Inc. | 11.04B | -4.46% | 1,090,639 | 982.02M |
| 14 | RVTY | Revvity, Inc. | 9.42B | -3.29% | 254,270 | 2.86B |
| 15 | QGEN | Qiagen N.V. | 8.46B | -1.78% | 644,551 | 2.09B |
| 16 | CRL | Charles River Laboratories International, Inc. | 7.82B | -3.86% | 383,691 | 4.02B |
| 17 | ICLR | ICON Public Limited Company | 7.80B | -0.88% | 490,076 | 8.10B |
| 18 | RDNT | RadNet, Inc. | 4.37B | -5.23% | 397,433 | 2.04B |
| 19 | SHC | Sotera Health Company | 3.76B | -2.36% | 1,178,996 | 1.16B |
| 20 | BLLN | BillionToOne, Inc. | 3.30B | 0.39% | 155,411 | 305.11M |
| 21 | TWST | Twist Bioscience Corporation | 2.72B | -4.96% | 556,896 | 391.56M |
| 22 | VCYT | Veracyte, Inc. | 2.41B | -7.56% | 500,677 | 517.15M |
| 23 | GRAL | GRAIL, Inc. | 1.97B | -8.07% | 390,444 | 147.17M |
| 24 | WGS | GeneDx Holdings Corp. | 1.70B | -5.35% | 600,519 | 427.54M |
| 25 | NEO | NeoGenomics, Inc. | 952.17M | -5.48% | 787,150 | 727.33M |
| 26 | OPK | OPKO Health, Inc. | 886.69M | -1.28% | 2,086,305 | 606.88M |
| 27 | CDNA | CareDx, Inc. | 854.29M | -4.52% | 249,571 | 379.81M |
| 28 | CSTL | Castle Biosciences, Inc. | 714.44M | -2.71% | 147,245 | 344.23M |
| 29 | PSNL | Personalis, Inc. | 671.74M | -12.30% | 2,100,671 | 69.65M |
| 30 | FLGT | Fulgent Genetics, Inc. | 485.95M | -4.95% | 298,493 | 322.67M |
| 31 | BNR | Burning Rock Biotech Limited | 428.51M | -12.11% | 28,505 | 77.14M |
| 32 | MYGN | Myriad Genetics, Inc. | 408.16M | -5.52% | 838,912 | 824.50M |
| 33 | PRE | Prenetics Global Limited | 344.98M | -3.85% | 105,195 | 92.39M |
| 34 | BDSX | Biodesix, Inc. | 139.94M | -2.77% | 45,976 | 88.50M |
| 35 | MDXH | MDxHealth SA | 124.73M | -6.67% | 139,308 | 107.88M |
| 36 | FONR | FONAR Corporation | 121.74M | 0.16% | 30,503 | 106.03M |
| 37 | IMDX | Insight Molecular Diagnostics Inc. | 111.94M | -15.33% | 228,110 | 4.06M |
| 38 | XGN | Exagen Inc. | 63.74M | -5.02% | 180,255 | 66.58M |
| 39 | PRPO | Precipio, Inc. | 45.22M | -2.75% | 20,461 | 22.80M |
| 40 | BIAF | bioAffinity Technologies, Inc. | 18.40M | -13.71% | 2,527,873 | 6.16M |
| 41 | MBAI | Check-Cap Ltd. | 11.37M | -4.88% | 41,272 | - |
| 42 | NOTV | Inotiv, Inc. | 9.30M | -0.98% | 157,035 | 514.03M |
| 43 | XWEL | XWELL, Inc. | 6.98M | -6.20% | 141,551 | 29.52M |
| 44 | QUCY | Mainz Biomed N.V. | 5.26M | -10.46% | 91,178 | 659.94K |
| 45 | NDRA | ENDRA Life Sciences Inc. | 4.97M | -7.19% | 52,157 | - |
| 46 | ADVB | Advanced Biomed Inc. | 4.53M | - | 22,040 | - |
| 47 | ISPC | iSpecimen Inc. | 1.45M | -5.92% | 1,021,673 | 3.35M |